Industry association · Germany · EU Transparency Register 682525635754-90
4
positions filed
in the 326 files tracked
3
legislative files
of 326 tracked
3
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1205 trade and business associations on this site, they rank #476 by legislative files engaged — a count of participation, not a measure of influence.
1.2
declared lobbying FTE
self-declared
€200K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2019
in the register since
Declares membership of
VDGH is full member of MedTech Europe
VDGH is corporate member of the german chemical Industry association (VCI)
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
Register category
Trade and business associations
Registered as
Verband der Diagnostica-Industrie (VDGH)
Head office
Berlin, Germany
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Work at VDGH - Verband der Diagnostica-Industrie e.V:? so we know who speaks for it.
Their record over time
VDGH - Verband der Diagnostica-Industrie e.V: filed 4 positions between 6 Oct 2025 and 10 Jun 2026, across 3 of the 326 legislative files tracked here, attaching a full position paper 3 times.
The Verband der Diagnostica-Industrie e.V. (VDGH) welcomes the December 2025 European Commission proposal for a targeted revision of Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). The draft includes essential and urgent measures to simplify regulatory procedures, reduce unnecessary administrative burdens and strengthen the long-term stability of the European diagnostic market, without…
Filed in German · English published by the European Commission
The Association of Diagnostica Industrie e.V. (VDGH) welcomes the European Commission’s plan to fundamentally modernise the regulatory framework for in vitro diagnostic medical devices and to strike a better balance between regulatory safety and economic feasibility.
Filed in German · English published by the European Commission
Stellungnahme zum Biotech Act I A. Grundsätzliches Der VDGH begrüßt die Initiative der Europäischen Kommission, mit dem Biotech Act I die Rahmenbedingungen für Forschung, Entwicklung, Skalierung und regulatorische Begleitung biotechnologischer Gesundheitsinnovationen in Europa zu verbessern.
Filed in German · English published by the European Commission
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
The VDGH expressly welcomes the European Commission’s efforts with regard to cardiovascular diseases. In this context, it is important to create low-threshold services for the population, for example in preventive hubs or pharmacies, even outside the statutory health insurance system. Laboratory diagnostics, including point-of-care diagnostics, are an essential component of early detection and screening.
Filed in German · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Everything on this page comes from VDGH - Verband der Diagnostica-Industrie e.V:’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.